Join

Compare · CV vs TMDX

CV vs TMDX

Side-by-side comparison of CapsoVision Inc. (CV) and TransMedics Group Inc. (TMDX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CV and TMDX operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • TMDX is the larger of the two at $3.00B, about 9.4x CV ($318.8M).
  • Over the past year, CV is up 78.0% and TMDX is down 21.0% - CV leads by 99.0 points.
  • CV has been more active in the news (4 items in the past 4 weeks vs 3 for TMDX).
  • TMDX has more recent analyst coverage (19 ratings vs 3 for CV).
PerformanceCV+78.02%TMDX-21.02%
2025-09-10+0.00%2026-09-10
MetricCVTMDX
Company
CapsoVision Inc.
TransMedics Group Inc.
Price
$6.56+2.98%
$85.10-1.49%
Market cap
$318.8M
$3.00B
1M return
-0.61%
-4.80%
1Y return
+78.02%
-21.02%
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ
NASDAQ
IPO
2025
2019
News (4w)
4
3
Recent ratings
3
19
TMDX

TransMedics Group Inc.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.